Company Description
WW International, Inc. provides weight management products and services in the United States, Germany, and internationally.
It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes.
The company also provides various digital subscription products to weight loss and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform, as well as allows members to inspire and support each other by sharing their experiences with other people on weight health journeys.
In addition, it licenses its trademarks and other intellectual property in food, beverages, and other weight management-relevant consumer products and services, as well as provides publishing services.
The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019.
WW International, Inc. was founded in 1963 and is headquartered in New York, New York.
Country | United States |
Founded | 1961 |
IPO Date | Nov 15, 2001 |
Industry | Personal Services |
Sector | Consumer Discretionary |
Employees | 3,700 |
CEO | Tara Comonte |
Contact Details
Address: 675 Avenue of the Americas, 6th Floor New York, New York 10010 United States | |
Phone | 212 589 2700 |
Website | corporate.ww.com |
Stock Details
Ticker Symbol | WW |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000105319 |
CUSIP Number | 98262P101 |
ISIN Number | US98262P1012 |
Employer ID | 11-6040273 |
SIC Code | 7200 |
Key Executives
Name | Position |
---|---|
Tara M. Comonte | President, Chief Executive Officer and Director |
Felicia DellaFortuna | Chief Financial Officer |
Nicole Haag | Corporate Controller and Principal Accounting Officer |
Jacqueline Cooke | Chief Legal and Administrative Officer and Secretary |
David Helderman | Director of Investor Relations |
Michael Amsel | Chief Marketing Officer |
Tony Yen | Head of Taiwan |
Donna Boyer | Chief Product Officer |
Phillip Picardi | Chief Impact Officer |
Scott Honken PharmD | Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 25, 2025 | SCHEDULE 13D | Filing |
Apr 21, 2025 | ARS | Filing |
Apr 21, 2025 | DEF 14A | Other definitive proxy statements |
Mar 21, 2025 | 8-K | Current Report |
Feb 28, 2025 | 10-K | Annual Report |
Feb 27, 2025 | 8-K | Current Report |
Feb 3, 2025 | 8-K | Current Report |
Nov 27, 2024 | 8-K | Current Report |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |